Evidence map›Paper›PMID 37508936›Full record

ReviewBrain sciences2023

Metacognition in Schizophrenia Spectrum Disorders-Current Methods and Approaches.

Petru Fabian Lungu, Corina-Miruna Lungu, Alin Ciobîcă, Ioana Miruna Balmus, Alexandra Boloș, Romeo Dobrin, Alina Costina Luca

Abstract readReview
In one paragraph

Review in Brain sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Petru Fabian LunguFaculty of Biology, Biology Department, "Alexandru Ioan Cuza" University, 700506 Iasi, Romania.
Corina-Miruna LunguFaculty of Psychology and Educational Sciences/Psychology Department, "Alexandru Ioan Cuza" University, 700506 Iasi, Romania.
Alin CiobîcăFaculty of Biology, Biology Department, "Alexandru Ioan Cuza" University, 700506 Iasi, Romania.
Ioana Miruna BalmusInstitute of Interdisciplinary Research, Department of Exact Sciences and Natural Sciences, "Alexandru Ioan Cuza" University, 700506 Iasi, Romania.
Alexandra BoloșDepartament of Psychiatry, "Grigore T. Popa", University of Medicine and Pharmacy, 700115 Iasi, Romania.
Romeo DobrinDepartament of Psychiatry, "Grigore T. Popa", University of Medicine and Pharmacy, 700115 Iasi, Romania.ORCID 0000-0003-3023-0205
Alina Costina LucaDepartment of Mother and Child Medicine-Pediatrics, "Grigore T. Popa", University of Medicine and Pharmacy, 700115 Iasi, Romania.ORCID 0000-0002-5676-0864

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metacognition essentially represents "thinking about thinking", or the individual's capacity to control and monitor their own cognitive processes. Metacognition impairment in schizophrenia represents a core feature of the disease, and, in the last fifteen years, the subject has evolved into a growing study area concentrating on a wide variety of processes, such as clinical insight, autobiographical memory, cognitive beliefs, reasoning, and memory biases. Since metacognition is a complex subject, we wanted to focus on the different nuances of metacognition transposed into the lives of patients diagnosed with either schizophrenia or a schizoaffective disorder. Therefore, this narrative review aims to analyze the literature in order to provide an insight regarding the current methods and approaches in the study of metacognition in schizophrenia or schizoaffective disorders, as well as the results provided. Results from the reviewed studies showed that patients with schizophrenia have a lower metacognitive ability, which is strongly reflected in their lives. Studies to date have highlighted the interaction between schizophrenia symptoms and metacognition, which shows how metacognition impacts work performance, autobiographical memory, motivation, the severity of symptoms, and social cognition.

Indexed as

measurementmetacognitionschizophreniatools

Identifiers

PMID37508936
PMCPMC10377717

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.